ArticleEpilepsia open2026
Computational protein stability analysis of SCN1A missense variants reveals domain-dependent stability patterns.
Article in Epilepsia open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo determine whether computational protein-stability predictions discriminate pathogenic from benign SCN1A missense variants, and to characterize the structural distribution of predicted destabilization among pathogenic variants.
methodsOn an AlphaFold3-predicted Nav1.1 structure, FoldX, and Rosetta Cartesian ΔΔG were computed for a single ClinVar snapshot of pathogenic/likely-pathogenic (P/LP) and benign/likely-benign (B/LB) missense variants and its extension to ClinVar variants of uncertain significance (VUS) and gnomAD v4.1 variants; membrane-aware RosettaMP was applied to the patch-clamp subgroup. Pathogenic variants were stratified by functional domain.
resultsPathogenic variants were more destabilizing than benign (FoldX 2.61 vs. 0.31 kcal/mol, p = 1.27 × 10 SIGNIFICANCE: Computational stability analysis thus adds a mechanistic layer complementary to the conventional gating-dysfunction view, distinguishing a destabilized pore-region subset-for which proteostasis impairment is a candidate, though unproven, mechanism-from a structurally tolerated S4 subset whose pathogenicity is stability-independent. As a hypothesis-generating rather than mechanism-defining approach, this stratification prioritizes candidate variants-including the 18.5% of VUS that are strongly destabilizing-for direct functional and surface-expression validation in SCN1A-related epilepsies. PLAIN LANGUAGE SUMMARY: We used computational modeling to predict how thousands of SCN1A genetic variants influence the stability of the Nav1.1 sodium channel protein. Disease-causing variants tended to destabilize the protein more than benign variants, and variants in the pore region-where ions flow through the channel-were predominantly destabilizing. This is consistent with loss-of-function arising from misfolding and degradation of the channel protein in this subset of variants. By contrast, variants in the voltage-sensing region were often structurally tolerated, indicating that their disease-causing effects likely arise through a different mechanism that requires direct functional measurement to define. Accordingly, the analysis nominates a candidate pore-region subset potentially affected by proteostasis impairment and a complementary stability-neutral subset warranting functional evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.